Lepu Competitors

300003 Stock

17.88 0.52 2.83%

Lepu Medical Tech competes with Jafron Biomedical, Cofoe Medical, Double Medical, Jiangsu Apon, and Maider Medical; as well as few others. The company operates under Health Care Equipment & Supplies sector and is part of Health Care industry. Analyzing Lepu Medical competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Lepu Medical to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Lepu Medical Correlation with its peers.

Lepu Medical vs Winner Medical Correlation

Good diversification

The correlation between Lepu Medical Tech and 300888 is -0.15 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Lepu Medical Tech and 300888 in the same portfolio, assuming nothing else is changed.

Moving together with Lepu Stock

0.74

002582

Haoxiangni Jujube

Pair Corr

Moving against Lepu Stock

0.52	601919	COSCO SHIPPING Holdings	Pair Corr
0.45	508096	AVIC Fund Management	Pair Corr
0.38	180401	Penghua Shenzhen Energy	Pair Corr
0.31	603565	Shanghai Zhonggu Log	Pair Corr

Specify up to 10 symbols:

Hype

Prediction

Low	Estimated	High
14.68	17.88	21.08

Details

Intrinsic

Valuation

Low	Real	High
11.67	14.87	18.07

Details

Naive

Forecast

Low	Next	High
13.14	16.34	19.55

Details

Bollinger

Band Projection (param)

Lower	Middle Band	Upper
16.18	18.66	21.14

Details

Lepu Medical Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Lepu Medical and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Lepu and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Lepu Medical Tech does not affect the price movement of the other competitor.

	300529	301087	002901	300753	688310	688050	600055	688085	300888
300529		0.32	0.55	0.48	0.55	0.68	0.4	0.56	0.47	300529
301087	0.32		0.59	0.87	0.01	0.19	0.79	0.6	-0.49	301087
002901	0.55	0.59		0.65	0.51	0.59	0.45	0.55	-0.07	002901
300753	0.48	0.87	0.65		0.26	0.44	0.75	0.52	-0.21	300753
688310	0.55	0.01	0.51	0.26		0.65	-0.05	0.51	0.44	688310
688050	0.68	0.19	0.59	0.44	0.65		0.23	0.27	0.51	688050
600055	0.4	0.79	0.45	0.75	-0.05	0.23		0.36	-0.2	600055
688085	0.56	0.6	0.55	0.52	0.51	0.27	0.36		-0.12	688085
300888	0.47	-0.49	-0.07	-0.21	0.44	0.51	-0.2	-0.12		300888
	300529	301087	002901	300753	688310	688050	600055	688085	300888

High positive correlations

300753	+ 0.87	301087
600055	+ 0.79	301087
600055	+ 0.75	300753
688050	+ 0.68	300529
300753	+ 0.65	002901
688050	+ 0.65	688310

High negative correlations

300888	- 0.49	301087
300888	- 0.21	300753
300888	- 0.2	600055
300888	- 0.12	688085
300888	- 0.07	002901
600055	- 0.05	688310

Risk-Adjusted Indicators

There is a big difference between Lepu Stock performing well and Lepu Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Lepu Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
300529	0.88	(0.11)	0.00	(0.90)	0.00	0.00	1.46	(1.58)	5.73
301087	2.02	0.32	0.13	(19.28)	1.95	(2.47)	4.94	(3.44)	17.43
002901	1.41	(0.05)	0.00	(0.29)	0.00	0.00	3.62	(3.28)	8.76
300753	3.39	0.22	0.05	0.57	3.50	(4.38)	10.94	(6.35)	31.11
688310	1.57	(0.23)	0.00	1.66	0.00	0.00	2.88	(4.64)	9.50
688050	1.06	(0.25)	0.00	(0.54)	0.00	0.00	2.50	(1.88)	7.09
600055	0.90	0.00	(0.03)	0.06	1.09	(1.10)	2.04	(2.06)	8.02
688085	1.92	0.18	0.07	(0.49)	1.86	(2.60)	5.12	(3.43)	22.42
300888	1.11	(0.19)	0.00	1.04	0.00	0.00	1.91	(2.77)	10.15

Lepu Medical Competitive Analysis

The better you understand Lepu Medical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Lepu Medical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Lepu Medical's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	300003	300529	301087	002901	300753	688310	688050	600055	688085	300888
	2.83 17.88 Lepu	1.57 20.01 Jafron	0.68 52.70 Cofoe	0.55 51.13 Double	2.07 32.67 Jiangsu	1.62 16.30 Maider	0.79 60.25 Eyebright	1.36 15.94 Beijing	3.19 21.88 Shanghai	2.77 35.40 Winner
Market Volatility (90 Days Market Risk)	Not too volatile	Very steady	Very steady	Very steady	Not too volatile	Not too volatile	Very steady	Very steady	Not too volatile	Very steady
Market Performance (90 Days Performance)	Weak	Weakest	Fair	Weak	Soft	Weakest	Weakest	Weak	Mild	Weakest
Odds of Financial Distress (Probability Of Bankruptcy)	Low	Low	Low	Low	Low	Low	Low	High	Low	Low
Current Valuation (Equity Enterprise Value)	Over Valued	Fairly Valued	Over Valued	Fairly Valued	Over Valued	Over Valued	Fairly Valued	Over Valued	Over Valued	Over Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available
Trade Advice (90 Days Macroaxis Advice)	Strong Sell	Cautious Hold	Strong Sell	Sell	Strong Sell	Strong Sell	Hold	Strong Sell	Strong Sell	Strong Sell
Net Asset	24.57 B	5.38 B	6.42 B	4.42 B	863.49 M	1.05 B	3.5 B	5.47 B	2.31 B	18.39 B
Profit Margin	0.0681	0.24	0.1	0.22	-0.0118	-0.0671	0.24	0.0089	0.13	0.0809
EBITDA	927.05 M	1.12 B	426.65 M	446.79 M	45.25 M	3.2 M	565.64 M	119.3 M	61.43 M	1.14 B
Operating Margin	0.29	0.27	0.15	0.36	0.0811	0.0551	0.24	-0.21	0.3	0.13
Current Valuation	35.81 B	15.18 B	9.54 B	20 B	4.16 B	2.36 B	11.64 B	8.11 B	7.06 B	20.09 B
Price To Book	2.12	4.73	2.35	6.31	6.18	3.31	4.18	2.39	3.63	1.85
Retained Earnings	9.43 B	2.51 B	764.13 M	1.53 B	190.03 M	153.02 M	949.5 M	1.06 B	572.18 M	6.78 B
Beta	0.25	0.48	0.96	0.22	0.61	0.51	0.57	-0.034	-0.16	0.24
Number Of Employees	8.81 K	2.8 K	5.1 K	4.5 K	608	657	2.29 K	1.19 K	514	15.64 K
Shares Outstanding	1.84 B	798.61 M	208.9 M	414.02 M	126.05 M	166.22 M	193.4 M	703.06 M	333.46 M	582.33 M
Cash Flow From Operations	734.64 M	1.05 B	663.39 M	442.3 M	15.68 M	56.56 M	347.75 M	218.25 M	10.96 M	1.27 B
Annual Yield	0.0162	0.0394	0.0339	0.0098	0.0019	N/A	0.0058	0.0082	2.0E-4	0.0192
Total Debt	4.18 B	1.19 B	548.61 M	328.35 M	76.72 M	43.14 M	579.07 M	26.46 M	31.63 M	3.35 B
Return On Equity	0.0234	0.14	0.0674	0.17	-0.0076	-0.0436	0.13	0.003	0.028	0.0764
Return On Asset	0.0188	0.0664	0.0299	0.074	-0.0093	-0.0185	0.0682	-0.007	0.014	0.0377
Book Value Per Share	8.7	4.43	23.2	8.21	5.4	4.92	14.53	6.81	6.22	19.88
Total Asset	24.57 B	5.38 B	6.42 B	4.42 B	863.49 M	1.05 B	3.5 B	5.47 B	2.31 B	18.39 B
Target Price	20.56	25.09	53.84	43.0	N/A	N/A	115.8	14.31	N/A	55.52
Last Dividend Paid	0.3	0.8	1.8	0.5	0.065	N/A	0.35	0.13	0.004	0.7
Shares Owned By Institutions	10.04	7.43	9.07	1.95	6.6	6.19	17.88	4.4	11.89	9.47
Market Capitalization	32.96 B	15.98 B	11.01 B	21.17 B	4.12 B	2.71 B	11.65 B	11.21 B	7.3 B	20.61 B
Price To Earnings To Growth	2.05	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Price To Sales	5.27	7.84	3.51	8.53	10.82	9.68	7.88	6.92	14.24	1.91
Net Income	197.29 M	820.2 M	311.75 M	385.29 M	10.8 M	(30.01 M)	388.4 M	158.64 M	12.11 M	695.38 M
Earnings Per Share	0.23	0.65	1.55	1.33	-0.04	-0.12	1.88	0.02	0.2	1.5
Shares Owned By Insiders	38.6	51.04	59.6	82.79	42.47	67.78	32.3	51.68	43.68	70.85
Revenue	6.1 B	2.68 B	2.98 B	2.14 B	403.8 M	274.85 M	1.41 B	1.52 B	453.6 M	8.98 B
Working Capital	4.82 B	2.02 B	2.56 B	1.87 B	332.82 M	446.25 M	881.72 M	3.92 B	808.8 M	2.81 B
Gross Profit	3.71 B	1.61 B	1.64 B	1.71 B	249.74 M	105.25 M	951.29 M	526.05 M	366.71 M	4.99 B
Day Typical Price	17.99	20.16	52.58	51.2	32.68	16.18	60.39	15.96	21.96	35.74
Accumulation Distribution	0.0391	0.0263	0.0309	0.0283	0.0343	0.0311	0.0166	0.0143	0.0608	0.0374
Market Facilitation Index	0.72	0.54	1.65	1.47	1.14	0.51	1.01	0.23	1.38	1.37
Daily Balance Of Power	(0.72)	(0.59)	(0.22)	0.1905	(0.61)	0.5098	(0.48)	(0.96)	(0.52)	(0.74)
Period Momentum Indicator	(0.52)	(0.32)	(0.36)	0.28	(0.69)	0.26	(0.48)	(0.22)	(0.72)	(1.01)
Rate Of Daily Change	0.97	0.98	0.99	1.01	0.98	1.02	0.99	0.99	0.97	0.97
Day Median Price	18.04	20.23	52.53	51.24	32.68	16.13	60.46	15.98	22.0	35.91
Price Action Indicator	(0.42)	(0.38)	(0.01)	0.035	(0.35)	0.31	(0.45)	(0.15)	(0.48)	(1.01)
Relative Strength Index	49.52	47.42	54.03	53.65	49.95	48.65	42.4	45.21	N/A	37.36
Coefficient Of Variation	4789.38	(1,246)	917.31	(5,550)	2282.6	(954.28)	(692.39)	35992.76	1713.27	(850.84)
Mean Deviation	1.76	0.8829	2.02	1.41	3.39	1.57	1.06	0.8998	1.92	1.11
Jensen Alpha	0.0435	(0.11)	0.3245	(0.05)	0.2178	(0.23)	(0.25)	(0)	0.1824	(0.19)
Total Risk Alpha	(0.1)	(0.17)	0.1759	(0.15)	(0.03)	(0.34)	(0.30)	(0.07)	0.021	(0.27)
Sortino Ratio	0.0105	N/A	0.1302	N/A	0.0537	N/A	N/A	(0.03)	0.0658	N/A
Downside Variance	4.5	N/A	4.93	N/A	13.49	N/A	N/A	1.41	4.23	N/A
Standard Deviation	3.22	1.24	3.06	2.11	5.53	2.17	1.53	1.31	3.09	1.56
Kurtosis	22.16	5.61	6.4	3.57	6.04	1.48	6.08	3.3	11.99	3.12
Potential Upside	3.77	1.46	4.94	3.62	10.94	2.88	2.5	2.04	5.12	1.91
Treynor Ratio	0.1446	(0.90)	(19.28)	(0.29)	0.5656	1.66	(0.54)	0.0558	(0.49)	1.04
Maximum Drawdown	25.01	5.73	17.43	8.76	31.11	9.5	7.09	8.02	22.42	10.15
Variance	10.4	1.54	9.38	4.45	30.54	4.71	2.33	1.72	9.53	2.44
Market Risk Adjusted Performance	0.1546	(0.89)	(19.27)	(0.28)	0.5756	1.67	(0.53)	0.0658	(0.48)	1.05
Risk Adjusted Performance	0.0229	(0.05)	0.0865	(0.01)	0.0404	(0.07)	(0.1)	0.0065	0.0499	(0.08)
Skewness	3.73	(1.01)	1.82	0.3412	2.0	(0.66)	(0.75)	0.995	2.53	0.515
Semi Deviation	2.04	N/A	1.95	N/A	3.5	N/A	N/A	1.09	1.86	N/A
Information Ratio	0.0069	(0.12)	0.0943	(0.04)	0.0357	(0.13)	(0.17)	(0.03)	0.0438	(0.15)
Value At Risk	(3.36)	(1.58)	(3.44)	(3.28)	(6.35)	(4.64)	(1.88)	(2.06)	(3.43)	(2.77)
Expected Short fall	(2.00)	N/A	(2.47)	N/A	(4.38)	N/A	N/A	(1.10)	(2.60)	N/A
Downside Deviation	2.12	N/A	2.22	N/A	3.67	N/A	N/A	1.19	2.06	N/A
Semi Variance	4.18	N/A	3.79	N/A	12.23	N/A	N/A	1.18	3.44	N/A

Lepu Medical Competition Performance Charts

Five steps to successful analysis of Lepu Medical Competition

Lepu Medical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Lepu Medical Tech in relation to its competition. Lepu Medical's competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of Lepu Medical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Lepu Medical's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Lepu Medical Tech, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Lepu Medical position

In addition to having Lepu Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Real Estate Thematic Idea Now

Real Estate

Publicly traded companies that are involved in real estate development, property maintenance and management of real estate investment trusts (REIT) funds. The Real Estate theme has 42 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Real Estate Theme or any other thematic opportunities.

View All Next

Launch

Other Information on Investing in Lepu Stock

Lepu Medical financial ratios help investors to determine whether Lepu Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lepu with respect to the benefits of owning Lepu Medical security.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Lepu Competitors

Lepu Medical vs Winner Medical Correlation

Good diversification

Moving together with Lepu Stock

Moving against Lepu Stock

Specify up to 10 symbols:

Lepu Medical Competition Correlation Matrix

High positive correlations

High negative correlations

Risk-Adjusted Indicators

Lepu Medical Competitive Analysis

Lepu Medical Competition Performance Charts

Five steps to successful analysis of Lepu Medical Competition

Complement your Lepu Medical position

Did You Try This Idea?

Run Real Estate Thematic Idea Now

Real Estate

Other Information on Investing in Lepu Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY